دورية أكاديمية

First in Human Clinical Responses and Persistence Data on TEG001: A Next Generation of Engineered Αβ T Cells Targeting AML and MM with a High Affinity γ9δ2TCR

التفاصيل البيبلوغرافية
العنوان: First in Human Clinical Responses and Persistence Data on TEG001: A Next Generation of Engineered Αβ T Cells Targeting AML and MM with a High Affinity γ9δ2TCR
المؤلفون: de Witte, Moniek *, Scheepstra, Jojanneke *, Weertman, Naomi *, Daudeij, Annet *, van der Wagen, Lotte *, Oostvogels, Rimke *, de Haar, Colin *, Prins, Henk-Jan *, Dohmen, Willem *, Bartels-Wilmer, Carly *, Johanna, Inez *, Sebestyen, Zsolt *, Kuball, Jurgen, Straetemans, Trudy *
المصدر: In Blood 15 November 2022 140 Supplement 1:12737-12739
قاعدة البيانات: ScienceDirect
الوصف
تدمد:00064971
DOI:10.1182/blood-2022-158191